TY - JOUR
T1 - Structure and dynamics of the liver receptor homolog 1-PGC1α complex
AU - Mays, Suzanne G.
AU - Okafor, C. Denise
AU - Tuntland, Micheal L.
AU - Whitby, Richard J.
AU - Dharmarajan, Venkatasubramanian
AU - Stec, Józef
AU - Griffin, Patrick R.
AU - Ortlund, Eric A.
N1 - Funding Information:
This work was supported in part by the National Institutes of Health [Grants T32-GM008602, F31-DK111171, R01-DK095750, K12-GM000680, 1S10RR027270, and R01-DK105825] and an Emory Catalyst Grant. R.J.W. and J.S. thank GlaxoSmithKline for generous funding.
Publisher Copyright:
© 2017 by The American Society for Pharmacology and Experimental Therapeutics.
PY - 2017/7
Y1 - 2017/7
N2 - Peroxisome proliferator-activated gamma coactivator 1-α (PGC1α) regulates energy metabolism by directly interacting with transcription factors to modulate gene expression. Among the PGC1α binding partners is liver receptor homolog 1 (LRH-1; NR5A2), an orphan nuclear hormone receptor that controls lipid and glucose homeostasis. Although PGC1α is known to bind and activate LRH-1, mechanisms through which PGC1α changes LRH-1 conformation to drive transcription are unknown. Here, we used biochemical and structural methods to interrogate the LRH-1-PGC1α complex. Purified, full-length LRH-1, as well as isolated ligand binding domain, bound to PGC1α with higher affinity than to the coactivator, nuclear receptor coactivator-2 (Tif2), in coregulator peptide recruitment assays. We present the first crystal structure of the LRH-1-PGC1α complex, which depicts several hydrophobic contacts and a strong charge clamp at the interface between these partners. In molecular dynamics simulations, PGC1α induced correlated atomic motion throughout the entire LRH-1 activation function surface, which was dependent on charge-clamp formation. In contrast, Tif2 induced weaker signaling at the activation function surface than PGC1α but promoted allosteric signaling from the helix 6/β-sheet region of LRH-1 to the activation function surface. These studies are the first to probe mechanisms underlying the LRH-1-PGC1α interaction and may illuminate strategies for selective therapeutic targeting of PGC1α-dependent LRH-1 signaling pathways.
AB - Peroxisome proliferator-activated gamma coactivator 1-α (PGC1α) regulates energy metabolism by directly interacting with transcription factors to modulate gene expression. Among the PGC1α binding partners is liver receptor homolog 1 (LRH-1; NR5A2), an orphan nuclear hormone receptor that controls lipid and glucose homeostasis. Although PGC1α is known to bind and activate LRH-1, mechanisms through which PGC1α changes LRH-1 conformation to drive transcription are unknown. Here, we used biochemical and structural methods to interrogate the LRH-1-PGC1α complex. Purified, full-length LRH-1, as well as isolated ligand binding domain, bound to PGC1α with higher affinity than to the coactivator, nuclear receptor coactivator-2 (Tif2), in coregulator peptide recruitment assays. We present the first crystal structure of the LRH-1-PGC1α complex, which depicts several hydrophobic contacts and a strong charge clamp at the interface between these partners. In molecular dynamics simulations, PGC1α induced correlated atomic motion throughout the entire LRH-1 activation function surface, which was dependent on charge-clamp formation. In contrast, Tif2 induced weaker signaling at the activation function surface than PGC1α but promoted allosteric signaling from the helix 6/β-sheet region of LRH-1 to the activation function surface. These studies are the first to probe mechanisms underlying the LRH-1-PGC1α interaction and may illuminate strategies for selective therapeutic targeting of PGC1α-dependent LRH-1 signaling pathways.
UR - http://www.scopus.com/inward/record.url?scp=85020182278&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020182278&partnerID=8YFLogxK
U2 - 10.1124/mol.117.108514
DO - 10.1124/mol.117.108514
M3 - Article
C2 - 28363985
AN - SCOPUS:85020182278
SN - 0026-895X
VL - 92
SP - 1
EP - 11
JO - Molecular pharmacology
JF - Molecular pharmacology
IS - 1
ER -